Altre lingue CEN Biotech, Inc.

Azioni

CENBF

CA15130L1040

Mercato chiuso - OTC Markets Altri mercati azionari 17:49:14 29/04/2024			Variaz. 5gg	Var. 1 gen.
0,00738 ^USD	+138,06%		+138,71%	+146,67%

2023	CEN Biotech, Inc. annuncia le dimissioni di Lawrence Lehoux da membro del Consiglio di Amministrazione e Chief Technology Officer	CI
2022	CEN Biotech, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2022	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	29/03/23
CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer	29/03/23
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS	14/11/22
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	16/09/22
CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	07/09/22
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	31/08/22
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS	22/08/22
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22/08/22
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	20/07/22
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	27/05/22
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	26/05/22
CEN Biotech, Inc. announced that it has received $0.07 million in funding from 1800 Diagonal Lending, LLC	24/05/22
NOTE 2 - GOING CONCERN UNCERTAINTY / MANAGEMENT PLANS	20/05/22
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/05/22
CEN BIOTECH INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	05/05/22
CEN BIOTECH INC : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21/04/22
CEN Biotech, Inc. Announces Changes to Its Board	21/04/22
CEN BIOTECH INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	19/04/22
CEN Biotech, Inc. Announces Management Changes	19/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CEN Biotech, Inc.

Azioni

CENBF

CA15130L1040

Altre lingue

Filtri